Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction

Journal of the American College of Cardiology

Volumn 45, Issue 5, 2005, Pages 661-667

  Kasama, Shu ^a   Toyama, Takuji ^a   Kumakura, Hisao ^b   Takayama, Yoshiaki ^b   Ichikawa, Shuichi ^b   Suzuki, Tadashi ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Cardiovasc Hosp of Central Japan   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; IODINE 123; LOOP DIURETIC AGENT; PERINDOPRIL; PLACEBO; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART SCINTISCANNING; HUMAN; MALE; MEDIASTINUM; MEDICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STANDARD; SYMPATHETIC TONE; TREATMENT OUTCOME;

EID: 14044251380     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.038     Document Type: Article

References (32)

1. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr, D.W. Mahoney, K.R. Bailey, R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
2. S. Yusuf, M.A. Pfeffer, K. Swedberg, the CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial Lancet 362 2003 777 781
3. J. McMurray, J. Ostergren, M. Pfeffer, the CHARM Committees and Investigators Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program Eur J Heart Fail 5 2003 261 270
4. E.B. Henderson, J.K. Kahn, J.R. Corbett Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy Circulation 78 1988 1192 1199
5. J. Schofer, R. Spielmann, A. Schuchert, K. Weber, M. Schluter Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 12 1988 1252 1258
6. P. Merlet, H. Valette, J.L. Dubois-Rande Prognostic value of cardiac meta-iodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471 477
7. Y. Takeishi, H. Atsumi, S. Fujiwara, K. Takahashi, H. Tomoike ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure J Nucl Med 38 1997 1085 1089
8. T. Toyama, Y. Aihara, T. Iwasaki Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy J Nucl Med 40 1999 217 223
9. T. Toyama, H. Hoshizaki, R. Seki Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy J Nucl Med 44 2003 1604 1611
10. S. Kasama, T. Toyama, H. Hoshizaki Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy Chest 122 2002 542 548
11. S. Kasama, T. Toyama, H. Kumakura Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure J Nucl Med 43 2002 1279 1285
12. S. Kasama, T. Toyama, H. Kumakura Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy J Am Coll Cardiol 41 2003 574 581
13. S. Kasama, T. Toyama, H. Kumakura Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure J Nucl Med 44 2003 884 890
14. S. Kasama, T. Toyama, H. Kumakura Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure J Nucl Med 45 2004 1108 1113
15. N.B. Schiller, P.M. Shah, M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
16. L. Baruch, I. Anand, I.S. Cohen, S. Ziesche, D. Judd, J.N. Cohn the Vasodilator Heart Failure Trial (V-HeFT) Study Group Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure Circulation 99 1999 2658 2664
17. H. Urata, B. Healy, R.W. Stewart, F.M. Bumpus, A. Husain Angiotensin II-forming pathways in normal and failing human hearts Circ Res 66 1990 883 890
18. E. Balcells, Q.C. Meng, W.H. Johnson Jr Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations Am J Physiol 273 1997 H1769 H1774
19. F.M. Bumpus, K.J. Catt, A.T. Chiu Nomenclature for angiotensin receptors: a report of the Nomenclature Committee of the Council for High Blood Pressure Research Hypertension 17 1991 720 721
20. J.N. Cohn, G. Tognoni the Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
21. 131I]iodobenzylguanidine J Nucl Med 21 1980 349 353
22. A.D. Struthers Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure J Card Fail 2 1996 47 54
23. L. Barki-Harrington, L.M. Luttrell, H.A. Rockman Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo Circulation 108 2003 1611 1618
24. H.A. Rockman, W.J. Koch, R.J. Lefkowitz Seven-transmembrane-spanning receptors and heart function Nature 415 2002 206 212
25. T. Tsutamoto, A. Wada, K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
26. H. Yasue, M. Yoshimura, H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
27. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
28. R. Latini, S. Masson, I. Anand, for the Val-HeFT Investigators The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 2004 292 299
29. Y. Mizuno, M. Yoshimura, H. Yasue Aldosterone production is activated in failing ventricle in humans Circulation 103 2001 72 77
30. M. Yoshimura, S. Nakamura, T. Ito Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction J Clin Endocrinol Metab 87 2002 3936 3940
31. E. Harada, M. Yoshimura, H. Yasue Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes Circulation 104 2001 137 139
32. K. Sakata, M. Shirotani, H. Yoshida, C. Kurata Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension J Am Coll Cardiol 32 1998 438 443